Christoph J Auernhammer
Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms
Zitzmann K, Vlotides G, Brand S, Lahm H, Spöttl G, Göke B, Auernhammer C. Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms. Endocr Relat Cancer 2012; 19:423-34.
May 24, 2012Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms
May 24, 2012Endocr Relat Cancer 2012; 19:423-34
Zitzmann Kathrin, Vlotides George, Brand Stephan, Lahm Harald, Spöttl Gerald, Göke Burkhard, Auernhammer Christoph J
The novel Raf inhibitor Raf265 decreases Bcl-2 levels and confers TRAIL-sensitivity to neuroendocrine tumour cells
Zitzmann K, de Toni E, von Rüden J, Brand S, Göke B, Laubender R, Auernhammer C. The novel Raf inhibitor Raf265 decreases Bcl-2 levels and confers TRAIL-sensitivity to neuroendocrine tumour cells. Endocr Relat Cancer 2011; 18:277-85.
Mar 21, 2011The novel Raf inhibitor Raf265 decreases Bcl-2 levels and confers TRAIL-sensitivity to neuroendocrine tumour cells
Mar 21, 2011Endocr Relat Cancer 2011; 18:277-85
Zitzmann Kathrin, de Toni Enrico, von Rüden Janina, Brand Stephan, Göke Burkhard, Laubender Rüdiger P, Auernhammer Christoph J
Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus
Diegelmann J, Beigel F, Zitzmann K, Kaul A, Göke B, Auernhammer C, Bartenschlager R, Diepolder H, Brand S. Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus. PloS one 2010; 5:e15200.
Dec 8, 2010Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus
Dec 8, 2010PloS one 2010; 5:e15200
Diegelmann Julia, Beigel Florian, Zitzmann Kathrin, Kaul Artur, Göke Burkhard, Auernhammer Christoph J, Bartenschlager Ralf, Diepolder Helmut M, Brand Stephan
Compensatory activation of Akt in response to mTOR and Raf inhibitors - a rationale for dual-targeted therapy approaches in neuroendocrine tumor disease
Zitzmann K, Rüden J, Brand S, Göke B, Lichtl J, Spöttl G, Auernhammer C. Compensatory activation of Akt in response to mTOR and Raf inhibitors - a rationale for dual-targeted therapy approaches in neuroendocrine tumor disease. Cancer Lett 2010; 295:100-9.
Mar 30, 2010Compensatory activation of Akt in response to mTOR and Raf inhibitors - a rationale for dual-targeted therapy approaches in neuroendocrine tumor disease
Mar 30, 2010Cancer Lett 2010; 295:100-9
Zitzmann Kathrin, Rüden Janina von, Brand Stephan, Göke Burkhard, Lichtl Jennifer, Spöttl Gerald, Auernhammer Christoph J
The role of interleukin-22 in hepatitis C virus infection
Dambacher J, Beigel F, Zitzmann K, Heeg M, Göke B, Diepolder H, Auernhammer C, Brand S. The role of interleukin-22 in hepatitis C virus infection. Cytokine 2008; 41:209-16.
Jan 11, 2008The role of interleukin-22 in hepatitis C virus infection
Jan 11, 2008Cytokine 2008; 41:209-16
Dambacher Julia, Beigel Florian, Zitzmann Kathrin, Heeg Malte H J, Göke Burkhard, Diepolder Helmut M, Auernhammer Christoph J, Brand Stephan
SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells
Zitzmann K, Brand S, De Toni E, Baehs S, Göke B, Meinecke J, Spöttl G, Meyer H, Auernhammer C. SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells. Cancer Res 2007; 67:5025-32.
May 15, 2007SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells
May 15, 2007Cancer Res 2007; 67:5025-32
Zitzmann Kathrin, Brand Stephan, De Toni Enrico N, Baehs Sebastian, Göke Burkhard, Meinecke Jennifer, Spöttl Gerald, Meyer Heinrich H H D, Auernhammer Christoph J
Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease
Dambacher J, Beigel F, Seiderer J, Haller D, Göke B, Auernhammer C, Brand S. Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease. Gut 2007; 56:1257-65.
Apr 20, 2007Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease
Apr 20, 2007Gut 2007; 56:1257-65
Dambacher Julia, Beigel Florian, Seiderer Julia, Haller Dirk, Göke Burkhard, Auernhammer Christoph J, Brand Stephan
The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells
Zitzmann K, De Toni E, Brand S, Göke B, Meinecke J, Spöttl G, Meyer H, Auernhammer C. The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells. Neuroendocrinology 2007; 85:54-60.
Feb 19, 2007The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells
Feb 19, 2007Neuroendocrinology 2007; 85:54-60
Zitzmann Kathrin, De Toni Enrico N, Brand Stephan, Göke Burkhard, Meinecke Jennifer, Spöttl Gerald, Meyer Heinrich H D, Auernhammer Christoph J
IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro
Brand S, Thasler W, Bilzer M, Diepolder H, Göke B, Storr M, Steib C, Olszak T, Prüfer T, Weiss T, Heeg M, Zitzmann K, Beigel F, Dambacher J, Auernhammer C. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro. Am J Physiol Gastrointest Liver Physiol 2007; 292:G1019-28.
Jan 4, 2007IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro
Jan 4, 2007Am J Physiol Gastrointest Liver Physiol 2007; 292:G1019-28
Brand Stephan, Thasler Wolfgang E, Bilzer Manfred, Diepolder Helmut, Göke Burkhard, Storr Martin, Steib Christian J, Olszak Torsten, Prüfer Thomas, Weiss Thomas S, Heeg Malte H J, Zitzmann Kathrin, Beigel Florian, Dambacher Julia, Auernhammer Christoph J
Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells
Zitzmann K, Brand S, Baehs S, Göke B, Meinecke J, Spöttl G, Meyer H, Auernhammer C. Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells. Biochem Biophys Res Commun 2006; 344:1334-41.
Apr 24, 2006Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells
Apr 24, 2006Biochem Biophys Res Commun 2006; 344:1334-41
Zitzmann Kathrin, Brand Stephan, Baehs Sebastian, Göke Burkhard, Meinecke Jennifer, Spöttl Gerald, Meyer Heinrich, Auernhammer Christoph J
IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration
Brand S, Auernhammer C, Göke B, Ochsenkühn T, Seiderer J, Herrmann K, Leclair S, Popp A, Jagla W, Marquardt A, Diepolder H, Otte J, Eichhorst S, Zitzmann K, Olszak T, Beigel F, Dambacher J. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 2006; 290:G827-38.
Apr 1, 2006IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration
Apr 1, 2006Am J Physiol Gastrointest Liver Physiol 2006; 290:G827-38
Brand Stephan, Auernhammer Christoph J, Göke Burkhard, Ochsenkühn Thomas, Seiderer Julia, Herrmann Karin, Leclair Stéphane, Popp Andreas, Jagla Wolfgang, Marquardt Andreas, Diepolder Helmut, Otte Jan-Michel, Eichhorst Sören T, Zitzmann Kathrin, Olszak Torsten, Beigel Florian, Dambacher Julia
The Novel Lambda-Interferons IL-28A and IL-29 Mediate Proinflammatory, Antiproliferative, and Antiviral Signals in Intestinal Epithelial Cells
Brand S, Auernhammer C, Adler B, Diepolder H, Göke B, Otte J, Eichhorst S, Zitzmann K, Olszak T, Beigel F, Dambacher J. The Novel Lambda-Interferons IL-28A and IL-29 Mediate Proinflammatory, Antiproliferative, and Antiviral Signals in Intestinal Epithelial Cells. Gastroenterology 2005; 129:371-371.
Oct 4, 2005The Novel Lambda-Interferons IL-28A and IL-29 Mediate Proinflammatory, Antiproliferative, and Antiviral Signals in Intestinal Epithelial Cells
Oct 4, 2005Gastroenterology 2005; 129:371-371
Brand Stephan, Auernhammer Christoph J, Adler Barbara, Diepolder Helmut, Göke B, Otte J-M, Eichhorst Soeren T, Zitzmann K, Olszak Torsten, Beigel F, Dambacher J
IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression
Brand S, Göke B, Auernhammer C, Adler B, Diepolder H, Diebold J, Otte J, Eichhorst S, Zitzmann K, Olszak T, Beigel F, Dambacher J. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol 2005; 289:G960-8.
Jul 28, 2005IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression
Jul 28, 2005Am J Physiol Gastrointest Liver Physiol 2005; 289:G960-8
Brand Stephan, Göke Burkhard, Auernhammer Christoph J, Adler Barbara, Diepolder Helmut, Diebold Joachim, Otte Jan-Michel, Eichhorst Sören T, Zitzmann Kathrin, Olszak Torsten, Beigel Florian, Dambacher Julia
SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29
Brand S, Diepolder H, Göke B, Eichhorst S, Vlotides G, Olszak T, Beigel F, Dambacher J, Zitzmann K, Auernhammer C. SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29. Biochem Biophys Res Commun 2005; 331:543-8.
Jun 3, 2005SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29
Jun 3, 2005Biochem Biophys Res Commun 2005; 331:543-8
Brand Stephan, Diepolder Helmut, Göke Burkhard, Eichhorst Sören T, Vlotides George, Olszak Torsten, Beigel Florian, Dambacher Julia, Zitzmann Kathrin, Auernhammer Christoph J
SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA
Vlotides G, Sörensen A, Kopp F, Zitzmann K, Cengic N, Brand S, Zachoval R, Auernhammer C. SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA. Biochem Biophys Res Commun 2004; 320:1007-14.
Jul 30, 2004SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA
Jul 30, 2004Biochem Biophys Res Commun 2004; 320:1007-14
Vlotides George, Sörensen Astrid S, Kopp Florian, Zitzmann Kathrin, Cengic Neziha, Brand Stephan, Zachoval Reinhart, Auernhammer Christoph J